Unitedhealth Group Inc (UNH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,458,000 | 3,200,000 | -1,221,000 | 23,144,000 | 17,469,000 |
| Depreciation Amortization | 3,058,000 | 2,017,000 | 997,000 | 3,972,000 | 2,998,000 |
| Income taxes - deferred | -234,000 | -358,000 | -27,000 | -245,000 | -494,000 |
| Accounts receivable | 685,000 | -2,471,000 | -6,162,000 | -3,114,000 | -2,574,000 |
| Accounts payable and accrued liabilities | 2,235,000 | 777,000 | 2,069,000 | 3,482,000 | 3,837,000 |
| Other Working Capital | 1,001,000 | -6,333,000 | -6,242,000 | 1,643,000 | 13,496,000 |
| Other Operating Activity | 5,632,000 | 11,058,000 | 11,730,000 | 186,000 | -471,000 |
| Operating Cash Flow | $21,835,000 | $7,890,000 | $1,144,000 | $29,068,000 | $34,261,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,587,000 | -1,596,000 | -743,000 | -3,386,000 | -2,427,000 |
| Net Acquisitions | -11,674,000 | -3,031,000 | -3,006,000 | -9,451,000 | -8,389,000 |
| Purchase Of Investment | -19,951,000 | -10,130,000 | -4,798,000 | -18,314,000 | -12,998,000 |
| Sale Of Investment | 21,803,000 | 9,909,000 | 5,290,000 | 16,537,000 | 10,148,000 |
| Other Investing Activity | -6,999,000 | -8,909,000 | -3,083,000 | -960,000 | -721,000 |
| Investing Cash Flow | $-19,408,000 | $-13,757,000 | $-6,340,000 | $-15,574,000 | $-14,387,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -191,000 | 8,615,000 | 6,189,000 | 11,000 | 1,579,000 |
| Debt Issued | 17,811,000 | 5,925,000 | 5,925,000 | 6,394,000 | 6,394,000 |
| Debt Repayment | -2,500,000 | -1,750,000 | -750,000 | -2,125,000 | -2,125,000 |
| Common Stock Issued | 1,611,000 | 744,000 | 486,000 | 1,353,000 | 1,039,000 |
| Common Stock Repurchased | -4,028,000 | -3,072,000 | -3,072,000 | -8,000,000 | -6,500,000 |
| Dividend Paid | -5,601,000 | -3,664,000 | -1,729,000 | -6,761,000 | -5,023,000 |
| Other Financing Activity | -2,272,000 | 237,000 | 1,182,000 | -2,401,000 | 263,000 |
| Financing Cash Flow | $4,830,000 | $7,035,000 | $8,231,000 | $-11,529,000 | $-4,373,000 |
| Exchange Rate Effect | -30,000 | -44,000 | -48,000 | 97,000 | 49,000 |
| Beginning Cash Position | 25,427,000 | 25,427,000 | 25,427,000 | 23,365,000 | 23,365,000 |
| End Cash Position | 32,400,000 | 26,286,000 | 28,414,000 | 25,427,000 | 38,915,000 |
| Net Cash Flow | $6,973,000 | $859,000 | $2,987,000 | $2,062,000 | $15,550,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,835,000 | 7,890,000 | 1,144,000 | 29,068,000 | 34,261,000 |
| Capital Expenditure | -2,587,000 | -1,596,000 | -743,000 | -3,386,000 | -2,427,000 |
| Free Cash Flow | 19,248,000 | 6,294,000 | 401,000 | 25,682,000 | 31,834,000 |